While the behemoths of the Indian pharma industry are still battling the gaze of the USFDA and witnessing sharp erosion of their market cap, the clouds of uncertainty have receded for a niche player like Laurus Labs. Based in Hyderabad, in a span of about a decade, this mid-sized firm has become a leading manufacturer and developer of generic active pharmaceutical ingredients (APIs).
Laurus Labs is crucially poised, as investors look forward to its R&D efforts finally paying off
Summer wine and salad
Kishore Singh - January 19, 2015
The million-dollar question: Is investing a game of luck or skill?
Shankar Sharma - May 04, 2021
Every crisis is an opportunity, if you are on the right side of equities
Samir Arora - May 04, 2021
Viraj Mehta trusts the toughness and bounce of a company that has seen many trials
Viraj Mehta - May 04, 2021
Safir Anand spots a mid-sized company with the right chemistry and catalytic circumstances
Safir Anand - May 07, 2021